Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 16, 2013

D-Pharm, Gilead, Hanmi, Immune Pharma, Regeneron, Sanofi

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Immune’s bertilimumab boosted by mouse trial . . . read more Phase II D-Pharm begins stroke trial . . . read more Hanmi tests GLP-1 biologic against diabetes, obesity . . . read more Phase III Gilead’s Stribild posts efficacy, safety results . . . read more Sanofi, Regeneron cholesterol drug reduces LDL in monotherapy trial . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters